Transdermal Skin Patches Market Size, Share & Trends Analysis Report By Type (Multi-layer Drug-in-Adhesive), By Application (Pain Relief), By Distribution Channel, By Region, And Segment Forecasts, 2024

The global transdermal skin patches market was estimated at USD 7.82 billion in 2023 and is projected to grow at a CAGR of 5.0% from 2024 to 2030. The rising prevalence of chronic diseases such as cardiovascular disorders, diabetes, chronic pain, etc., increased consumer preference for minimally invasive treatment, the aging global population, and technological advancements in transdermal drug delivery systems have significantly boosted the market.

Transdermal patches provide a noninvasive, convenient alternative to traditional oral and injectable medications. They enhance patient compliance and minimize the gastrointestinal side effects that often accompany oral drugs. This ease of use and consistent drug release over extended periods make transdermal patches particularly attractive for managing chronic conditions.

The market is experiencing significant growth, primarily driven by the increasing prevalence of chronic diseases worldwide. According to the CDC report published in February 2024, an estimated 129 million people in the U.S. have at least 1 major chronic disease, such as cancer, heart disease, obesity, diabetes, and hypertension. Managing chronic pain typically involves regular administration of pain relief medication, which can be cumbersome with oral or injectable forms due to their side effects and the need for frequent dosing.

Transdermal patches offer a solution by providing a controlled release of medication over extended periods, which enhances patient compliance and improves therapeutic outcomes. For instance, the fentanyl transdermal patch, used for managing severe chronic pain, delivers the drug continuously for 72 hours, reducing the need for frequent dosing and maintaining steady pain relief.

Innovations in drug delivery systems, including microneedles, iontophoresis, and permeation enhancers, have significantly broadened the scope of transdermal medication delivery, accommodating large molecules and biologics. Microneedle patches create microscopic channels in the skin, enabling the administration of large molecule drugs that are otherwise difficult to deliver transdermal. A notable example is the microneedle patch for insulin delivery in diabetic patients, which offers a painless alternative to daily injections, potentially improving glycemic control. Iontophoresis, another breakthrough technology, employs a small electric charge to enhance drug penetration through the skin. For instance, IontoPatch delivers anti-inflammatory drugs to treat conditions like tendinitis and bursitis, increasing the drug's absorption and effectiveness. These advancements boost the efficiency and reliability of transdermal delivery systems and introduce new therapeutic possibilities, driving market growth and expanding the range of treatable conditions through non-invasive means.

The rising consumer preference for minimally invasive treatments significantly drives the market. Patients and healthcare providers favor these patches for reduced pain, lower infection risk, and fewer side effects than oral medications or injections. For instance, hormone replacement therapy patches Estraderm Mx Patch by Biochemie Novartis offer a steady hormone release, minimizing side effects linked to fluctuating levels seen with oral HRT. In addition, patches for smoking cessation, pain management, and neurological disorders provide a discreet and convenient drug delivery method. This non-invasive approach enhances patient comfort and compliance, boosting the market growth as awareness of these benefits spreads.

Global Transdermal Skin Patches Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global transdermal skin patches market based on type, application, distribution channel, and region:

Type Outlook (Revenue, USD Billion, 2018 - 2030)
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Matrix
Other Types
Application Outlook (Revenue, USD Billion, 2018 - 2030)
Pain Relief
Smoking Reduction and Cessation Aid
Cardiovascular Disorders
Neurological Disorders
Hormonal Therapy
Other Applications
Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

South Korea

Australia

Thailand

Latin America

Brazil

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Product Code: GVR-4-68040-361-1

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Application
- 1.2.3. Distribution Channel
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
  - 1.4.5.1. Data for primary interviews in North America
  - 1.4.5.2. Data for primary interviews in Europe
  - 1.4.5.3. Data for primary interviews in Asia Pacific
  - 1.4.5.4. Data for primary interviews in Latin America
  - 1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Application Outlook
- 2.2.3. Distribution Channel Outlook
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Transdermal Skin Patches Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.2.3. Industry Analysis - Porter's
  - 3.2.3.1. Bargaining power of the suppliers
  - 3.2.3.2. Bargaining power of the buyers
  - 3.2.3.3. Threats of substitution
  - 3.2.3.4. Threats from new entrants
  - 3.2.3.5. Competitive rivalry
- 3.2.4. PESTEL Analysis
  - 3.2.4.1. Political landscape
  - 3.2.4.2. Economic and Social landscape
  - 3.2.4.3. Technological landscape

Chapter 4. Transdermal Skin Patches Market: Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Transdermal Skin Patches Market: Type Movement Analysis, 2023 & 2030 (USD Billion)
- 4.2.1. Single-layer Drug-in-Adhesive
  - 4.2.1.1. Single-layer Drug-in-Adhesive Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 4.2.2. Multi-layer Drug-in-Adhesive
  - 4.2.2.1. Multi-layer Drug-in-Adhesive Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 4.2.3. Matrix
  - 4.2.3.1. Matrix Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 4.2.4. Other Types
  - 4.2.4.1. Other Types Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Transdermal Skin Patches Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Transdermal Skin Patches Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
- 5.2.1. Pain Relief
  - 5.2.1.1. Pain Relief Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 5.2.2. Smoking Reduction
  - 5.2.2.1. Smoking Reduction Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 5.2.3. Cardiovascular Disorders
  - 5.2.3.1. Cardiovascular Disorders Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 5.2.4. Neurological Disorders
  - 5.2.4.1. Neurological Disorders Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 5.2.5. Hormonal Therapy
  - 5.2.5.1. Hormonal Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 5.2.6. Other Applications
  - 5.2.6.1. Other Applications Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Transdermal Skin Patches Market: Distribution Channel Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Transdermal Skin Patches Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Billion)
- 6.2.1. Hospital Pharmacies
  - 6.2.1.1. Hospital Pharmacies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 6.2.2. Retail Pharmacies
  - 6.2.2.1. Retail Pharmacies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 6.2.3. Online Pharmacies
  - 6.2.3.1. Online Pharmacies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Transdermal Skin Patches Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
- 7.5.1. U.S.
  - 7.5.1.1. Key country dynamics
  - 7.5.1.2. Regulatory framework/ reimbursement structure
  - 7.5.1.3. Competitive scenario
  - 7.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.5.2. Canada
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Regulatory framework/ reimbursement structure
  - 7.5.2.3. Competitive scenario
  - 7.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.5.3. Mexico
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Regulatory framework/ reimbursement structure
  - 7.5.3.3. Competitive scenario
  - 7.5.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Billion)
7.6. Europe
- 7.6.1. UK
  - 7.6.1.1. Key country dynamics
  - 7.6.1.2. Regulatory framework/ reimbursement structure
  - 7.6.1.3. Competitive scenario
  - 7.6.1.4. UK market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.6.2. Germany
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Regulatory framework/ reimbursement structure
  - 7.6.2.3. Competitive scenario
  - 7.6.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.6.3. France
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Regulatory framework/ reimbursement structure
  - 7.6.3.3. Competitive scenario
  - 7.6.3.4. France market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.6.4. Italy
  - 7.6.4.1. Key country dynamics
  - 7.6.4.2. Regulatory framework/ reimbursement structure
  - 7.6.4.3. Competitive scenario
  - 7.6.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.6.5. Spain
  - 7.6.5.1. Key country dynamics
  - 7.6.5.2. Regulatory framework/ reimbursement structure
  - 7.6.5.3. Competitive scenario
  - 7.6.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.6.6. Norway
  - 7.6.6.1. Key country dynamics
  - 7.6.6.2. Regulatory framework/ reimbursement structure
  - 7.6.6.3. Competitive scenario
  - 7.6.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.6.7. Sweden
  - 7.6.7.1. Key country dynamics
  - 7.6.7.2. Regulatory framework/ reimbursement structure
  - 7.6.7.3. Competitive scenario
  - 7.6.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.6.8. Denmark
  - 7.6.8.1. Key country dynamics
  - 7.6.8.2. Regulatory framework/ reimbursement structure
  - 7.6.8.3. Competitive scenario
  - 7.6.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Billion)
7.7. Asia Pacific
- 7.7.1. Japan
  - 7.7.1.1. Key country dynamics
  - 7.7.1.2. Regulatory framework/ reimbursement structure
  - 7.7.1.3. Competitive scenario
  - 7.7.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.7.2. China
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Regulatory framework/ reimbursement structure
  - 7.7.2.3. Competitive scenario
  - 7.7.2.4. China market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.7.3. India
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Regulatory framework/ reimbursement structure
  - 7.7.3.3. Competitive scenario
  - 7.7.3.4. India market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.7.4. Australia
  - 7.7.4.1. Key country dynamics
  - 7.7.4.2. Regulatory framework/ reimbursement structure
  - 7.7.4.3. Competitive scenario
  - 7.7.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.7.5. South Korea
  - 7.7.5.1. Key country dynamics
  - 7.7.5.2. Regulatory framework/ reimbursement structure
  - 7.7.5.3. Competitive scenario
  - 7.7.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.7.6. Thailand
  - 7.7.6.1. Key country dynamics
  - 7.7.6.2. Regulatory framework/ reimbursement structure
  - 7.7.6.3. Competitive scenario
  - 7.7.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Billion)
7.8. Latin America
- 7.8.1. Brazil
  - 7.8.1.1. Key country dynamics
  - 7.8.1.2. Regulatory framework/ reimbursement structure
  - 7.8.1.3. Competitive scenario
  - 7.8.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.8.2. Argentina
  - 7.8.2.1. Key country dynamics
  - 7.8.2.2. Regulatory framework/ reimbursement structure
  - 7.8.2.3. Competitive scenario
  - 7.8.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Billion)
7.9. MEA
- 7.9.1. South Africa
  - 7.9.1.1. Key country dynamics
  - 7.9.1.2. Regulatory framework/ reimbursement structure
  - 7.9.1.3. Competitive scenario
  - 7.9.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.9.2. Saudi Arabia
  - 7.9.2.1. Key country dynamics
  - 7.9.2.2. Regulatory framework/ reimbursement structure
  - 7.9.2.3. Competitive scenario
  - 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.9.3. UAE
  - 7.9.3.1. Key country dynamics
  - 7.9.3.2. Regulatory framework/ reimbursement structure
  - 7.9.3.3. Competitive scenario
  - 7.9.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Billion)
- 7.9.4. Kuwait
  - 7.9.4.1. Key country dynamics
  - 7.9.4.2. Regulatory framework/ reimbursement structure
  - 7.9.4.3. Competitive scenario
  - 7.9.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
- 8.3.1. Key company market share analysis, 2023
- 8.3.2. Teva Pharmaceutical Industries Ltd
  - 8.3.2.1. Company overview
  - 8.3.2.2. Financial performance
  - 8.3.2.3. Type benchmarking
  - 8.3.2.4. Strategic initiatives
- 8.3.3. Novartis AG
  - 8.3.3.1. Company overview
  - 8.3.3.2. Financial performance
  - 8.3.3.3. Type benchmarking
  - 8.3.3.4. Strategic initiatives
- 8.3.4. Teikoku Pharma USA Inc.
  - 8.3.4.1. Company overview
  - 8.3.4.2. Financial performance
  - 8.3.4.3. Type benchmarking
  - 8.3.4.4. Strategic initiatives
- 8.3.5. Viatris Inc.
  - 8.3.5.1. Company overview
  - 8.3.5.2. Financial performance
  - 8.3.5.3. Type benchmarking
  - 8.3.5.4. Strategic initiatives
- 8.3.6. Johnson & Johnson
  - 8.3.6.1. Company overview
  - 8.3.6.2. Financial performance
  - 8.3.6.3. Type benchmarking
  - 8.3.6.4. Strategic initiatives
- 8.3.7. Luye Pharma Group
  - 8.3.7.1. Company overview
  - 8.3.7.2. Financial performance
  - 8.3.7.3. Type benchmarking
  - 8.3.7.4. Strategic initiatives
- 8.3.8. Purdue Pharma Manufacturing LP
  - 8.3.8.1. Company overview
  - 8.3.8.2. Financial performance
  - 8.3.8.3. Type benchmarking
  - 8.3.8.4. Strategic initiatives
- 8.3.9. Henan Lingrui Pharmaceutical Ltd
  - 8.3.9.1. Company overview
  - 8.3.9.2. Financial performance
  - 8.3.9.3. Type benchmarking
  - 8.3.9.4. Strategic initiatives
- 8.3.10. Samyang Biopharmaceuticals Corp.
  - 8.3.10.1. Company overview
  - 8.3.10.2. Financial performance
  - 8.3.10.3. Type benchmarking
  - 8.3.10.4. Strategic initiatives
- 8.3.11. Hisamitsu Pharmaceutical Co, Inc.
  - 8.3.11.1. Company overview
  - 8.3.11.2. Financial performance
  - 8.3.11.3. Type benchmarking
  - 8.3.11.4. Strategic initiatives

Product Code: GVR-4-68040-361-1

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 Global Transdermal Skin Patches Market, By Region, 2018 - 2030 (USD Billion)
Table 5 Global Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 6 Global Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 7 Global Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 8 North America Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
Table 9 North America Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 10 North America Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 11 North America Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 12 U.S. Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 13 U.S. Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 14 U.S. Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 15 Canada Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 16 Canada Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 17 Canada Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 18 Mexico Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 19 Mexico Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 20 Mexico Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 21 Europe Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
Table 22 Europe Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 23 Europe Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 24 Europe Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 25 UK Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 26 UK Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 27 UK Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 28 Germany Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 29 Germany Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 30 Germany Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 31 France Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 32 France Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 33 France Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 34 Italy Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 35 Italy Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 36 Italy Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 37 Spain Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 38 Spain Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 39 Spain Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 40 Denmark Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 41 Denmark Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 42 Denmark Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 43 Sweden Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 44 Sweden Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 45 Sweden Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 46 Norway Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 47 Norway Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 48 Norway Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 49 Asia Pacific Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
Table 50 Asia Pacific Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 51 Asia Pacific Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 52 Asia Pacific Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 53 Japan Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 54 Japan Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 55 Japan Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 56 China Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 57 China Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 58 China Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 59 India Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 60 India Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 61 India Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 62 South Korea Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 63 South Korea Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 64 South Korea Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 65 Australia Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 66 Australia Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 67 Australia Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 68 Thailand Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 69 Thailand Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 70 Thailand Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 71 Latin America Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
Table 72 Latin America Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 73 Latin America Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 74 Latin America Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 75 Brazil Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 76 Brazil Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 77 Brazil Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 78 Argentina Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 79 Argentina Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 80 Argentina Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 81 Middle East and Africa Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
Table 82 Middle East and Africa Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 83 Middle East and Africa Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 84 Middle East & Africa Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 85 South Africa Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 86 South Africa Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 87 South Africa Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 88 Saudi Arabia Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 89 Saudi Arabia Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 90 Saudi Arabia Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 91 UAE Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 92 UAE Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 93 UAE Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 94 Kuwait Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
Table 95 Kuwait Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
Table 96 Kuwait Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Transdermal Skin Patches market segment scope and defination
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2023)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter's five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Transdermal Skin Patches market: Type movement analysis
Fig. 17 Transdermal Skin Patches market: Type segment dashboard
Fig. 18 Transdermal Skin Patches market Type outlook: Key takeaways
Fig. 19 Single-layer Drug-in-Adhesive Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 20 Multi-layer Drug-in-AdhesiveTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 21 MatrixTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 22 Other TypesTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 23 Transdermal Skin Patches market: Application movement analysis
Fig. 24 Transdermal Skin Patches market Application outlook: Key takeaways
Fig. 25 Pain Relief Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 26 Smoking Reduction and Cessation Aid Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 27 Cardiovascular Disorders Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 28 Neurological Disorders Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 29 Hormonal Therapy Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 30 Other Applications Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 31 Transdermal Skin Patches market: Distribution Channel movement analysis
Fig. 32 Transdermal Skin Patches market Distribution Channel outlook: Key takeaways
Fig. 33 Hospital Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 34 Retail Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 35 Online Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 36 Regional outlook, 2023 & 2030
Fig. 37 Regional market dashboard
Fig. 38 Regional market place: Key takeaways
Fig. 39 North America Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 40 U.S. Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 41 Canada Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 42 Europe Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 43 UK Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 44 Germany Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 45 Spain Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 46 France Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 47 Italy implantable Market, 2018 - 2030 (USD Billion)
Fig. 48 Denmark Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 49 Sweden Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 50 Norway Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 51 Asia Pacific Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 52 Japan Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 53 China Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 54 India Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 55 South Korea Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 56 Australia Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 57 Thailand Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 58 Latin America Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 59 Brazil Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 60 Mexico Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 61 Argentina Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 62 MEA Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 63 South Africa Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 64 Saudi Arabia Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 65 UAE Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 66 Kuwait Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
Fig. 67 Heat map analysis
Fig. 68 Market differentiators

Transdermal Skin Patches Market Size, Share & Trends Analysis Report By Type (Multi-layer Drug-in-Adhesive), By Application (Pain Relief), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

Description

Table of Contents

List of Tables

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Transdermal Skin Patches Market Variables, Trends, & Scope

Chapter 4. Transdermal Skin Patches Market: Type Estimates & Trend Analysis

Chapter 5. Transdermal Skin Patches Market: Application Estimates & Trend Analysis

Chapter 6. Transdermal Skin Patches Market: Distribution Channel Estimates & Trend Analysis

Chapter 7. Transdermal Skin Patches Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

List of Tables

List of Figures